Delivery Order SPE2DB25D3504-SPE2DB25FVWBR
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide Montelukast Sodium 5 mg Chewable Tablets. The contract has a ceiling value of $1,278.43 and a period of performance through March 20, 2024. This delivery order is a part of a larger indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999 and a...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,275.23 firm fixed-price contract is for the supply of Montelukast Sodium 5 mg chewable tablets, with a performance period through April 1, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,593.98, is for the delivery of montelukast sodium 10 mg tablets. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary...
- The Defense Logistics Agency awarded a $3,876.85 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 4,562,179,126 montelukast sodium 5 mg chewable tablets. The delivery order was issued under an existing prime vendor contract vehicle to provide pharmaceutical products and services to DLA and the Department of Defense. Performance will take place at Amerisourcebergen's facility located in Conshohocken, Pennsylvania, with all supplies to be delivered between...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Montelukast Sodium 5 mg Chewable Tablets in quantities of 90s, with a ceiling value of $2,505.94 and a period of performance through May 2, 2025. The contract is a firm fixed-price, non-set-aside arrangement. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a $9,780 delivery order to Amerisourcebergen Drug Corporation for the supply of 90 boxes of Montelukast sodium 10 mg tablets. The contract has a firm fixed price and will be performed by Amerisourcebergen in Conshohocken, Pennsylvania between September 8-11, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense, this delivery order for a common asthma medication supports the Agency's mission to provide essential...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Montelukast Sodium 5 mg chewable tablets, a medication used to treat asthma and allergies. The contract has a firm fixed price, a ceiling value of $1,495.97, and an ultimate completion date of July 16, 2025. The contract is not set aside for any specific business type....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at approximately $2,242 to Amerisourcebergen Drug Corporation to supply 1,000 tablets of montelukast sodium 10 mg. The place of performance will be Amerisourcebergen's facility located in Conshohocken, Pennsylvania. The period of performance is September 11-12, 2023. As a major provider of pharmaceuticals and medical supplies to the Department of Defense globally, this order for a common asthma medication supports...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of 4,557,734,379 units of Montelukast Sodium 10 mg tablets. The award has a ceiling value of $4,756.49 and was issued on July 7, 2022, with a completion date of July 8, 2022. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a...
- The Defense Logistics Agency awarded a $2,132 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 50 boxes of montelukast sodium 4 mg chewable tablets. The place of performance is Amerisourcebergen's facility in Conshohocken, Pennsylvania. The period of performance is August 28-29, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will fulfill this order for the DLA's pharmaceutical supply needs. No set aside...
- SPE2DB25D3504Indefinite Delivery Contract
- SPE2DB25D3504-SPE2DB25FVWBRDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,366.73 to AmerisourceBergen Drug Corp for the supply of Montelukast Sodium 5 mg chewable tablets (90-count packaging). The award was made on August 22, 2025, with an ultimate completion date of August 25, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be delivered from the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical vendor for federal military and veteran healthcare systems. The company's DLA contract vehicle enables it to supply a broad range of pharmaceutical products, generic and brand-name medications, vaccines, and medical supplies across multiple therapeutic domains to support Defense Health Agency operations and other government healthcare customers. The firm's selection through competitive procurement demonstrates its capability to fulfill federal medical supply requirements, and this specific delivery order for Montelukast—an asthma and allergy medication—represents routine pharmaceutical fulfillment under the larger global pharmaceutical support contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/22/25 |